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Background: The biological actions of various ginseng extracts have been studied for treating obesity and
diabetes mellitus. However, few studies have evaluated the effects of fermented Korean Red Ginseng
(Panax ginseng Meyer) on metabolic syndrome. The present study evaluated the antiobesity and anti-
diabetic effects of fermented red ginseng (FRG) on old-aged, obese, leptin-deﬁcient (B6.V-Lepob, “ob/ob”)
mice.
Methods: The animals were divided into three groups and given water containing 0%, 0.5%, and 1.0% FRG
for 16 wk. The effect of FRG on ob/ob mice was determined by measuring changes in body weight, levels
of blood glucose, serum contents of triglycerides, total cholesterol and free fatty acids, messenger RNA
(mRNA) expressions of key factors associated with insulin action, such as insulin receptor (IR), lipo-
protein lipase (LPL), glucose transporter 1 and 4 (GLUT1 and GLUT4), peroxisome proliferators-activated
receptor gamma (PPAR-g), and phosphoenolpyruvate carboxykinase (PEPCK) in the liver and in muscle,
and histology of the liver and pancreas.
Results: FRG-treated mice had decreased body weight and blood glucose levels compared with control
ob/ob mice. However, anti-obesity effect of FRG was not evident rather than hypoglycemic effect in old
aged ob/ob mice. The hyperlipidemia in control group was attenuated in FRG-treated ob/ob mice. The
mRNA expressions of IR, LPL, GLUT1, GLUT4, PPAR-g, and PEPCK in the liver and in muscle were increased
in the FRG-treated groups compared with the control group.
Conclusion: These results suggest that FRG may play a vital role in improving insulin sensitivity relative
to reducing body weight in old-aged ob/ob mice.
Copyright  2015, The Korean Society of Ginseng, Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Obesity is excessive fat accumulation that is associated with
numerous health risks. A person with a body mass index of 30 is
generally considered obese [1]. According to data from a previous
survey, between 1999e2002 and 2007e2010, the age-adjusted
prevalence of obesity among adults aged 18 yr increased from
26.5% to 33.0% among men and from 32.4% to 34.9% among women
[2]. Obesity, a complex condition inﬂuenced by diet, developmental
stage, age, physical activity, and genetic factors [3], is a major riskToxicology, College of Veterinary
ht  2015, The Korean Society of G
c-nd/4.0/).factor for a number of chronic diseases including diabetes mellitus,
cardiovascular disease, and cancer [1]. In particular, type 2 diabetes
mellitus (noninsulin dependent diabetes mellitus) is closely asso-
ciated with obesity. Type 2 diabetes mellitus is caused by the
ineffective use of insulin resulting from excess body weight and
physical inactivity [4]. Along with the increased rates of obesity,
there has been a parallel increase in the prevalence of type 2 dia-
betes mellitus and impaired glucose tolerance [5]. The causes of
impaired glucose tolerance include insulin resistance associated
with obesity and type 2 diabetes mellitus. The term “insulinMedicine, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu 702-701,
inseng, Published by Elsevier Ltd. This is an open access article under the CC BY-NC-
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uptake, metabolism, or storage of glucose [6]. Pharmacological
agents (e.g., oral hypoglycemic agents and insulin) and the use of
complementary and alternative approaches for treating diabetes
mellitus, such botanicals with antihyperglycemic activities, are
being considered more frequently as treatment options by patients
and healthcare professionals [7,8]. Several studies on the use of
herbal medicine for treating obesity and diabetes mellitus have
been recently conducted [9,10].
Ginseng has been used in traditional herbal medicine for
>2000 yr in Asian countries including Korea, China, and Japan.
Commercially available ginseng is broadly categorized into three
types; (1) fresh ginseng is <4 yr old and has not been dried; (2)
white ginseng is 4w6 yr old, and has been peeled or either sun
dried or oven dried; and (3) red ginseng is older than 6 yr and is
steamed before being dried. The speciﬁc process for drying red
ginseng results in a nonenzymatic color change that gives its
characteristic hue. The various methods of preparing ginseng alter
the formation and concentration of saponinwithin the plant [11]. A
wide range of biological and biochemical actions of various ginseng
extracts have been studied. Clinical studies have shown that
ginseng improves psychological functions, immune functions, and
conditions associated with diabetes mellitus [8,12e15]. Asian
ginseng is known to facilitate blood ﬂow, alleviate fatigue, and
relieve oxidative stress under diabetic conditions through various
mechanisms such as the inhibition of lipid peroxidation [13]. The
berry of American ginseng (Panax quinquefolius L.) exerts signiﬁcant
antidiabetic and hypoglycemic effects in C57BL/6J ob/ob and C57BL/
Ks db/db mice [12,14]. Leptin-deﬁcient ob/ob mice are obese, hy-
perphagic, type 2 diabetic, have decreased body temperature,
hypogonadotropic, and suffer from hypogonadism [16]. Oral
administration of American ginseng berry juice signiﬁcantly
reduced high blood glucose levels and body weight in ob/ob mice
[8]. These studies showed that ginseng may be a suitable therapy
for treating diabetes mellitus. Fermented red ginseng (FRG) is
treated with microorganisms and enzymes that increase the
saponin content for maximum efﬁcacy [15]. FRG reduced the blood
glucose level in streptozotocin-induced diabetic rats [17]. Although
many studies have examined the properties of ginseng, no research
has been conducted to evaluate the effects of FRG on obesity and
diabetes mellitus in old-aged (>24-wk-old), obese mice. The pur-
pose of the present studywas to examine the effects of FRG on body
weight, blood glucose, serum contents of triglycerides, total
cholesterol and free fatty acids, changes in hepatic and pancreatic
histology, and messenger RNA (mRNA) expression of molecules
related to metabolism and insulin resistance in old-aged ob/ob
mice.
2. Materials and methods
2.1. Preparation of FRG
Two liters of distilled water was added to 300 g of 6-yr-old
white dried Korean ginseng (Panax ginsengMeyer) provided by the
Samkwang Company (Daejeon, Korea), and steamed for 24 h. A
further 4 L of distilled water was added, and the ginseng solution
was steamed at 90C for 48 h to make the red ginseng (RG) ex-
tracts. The RG extracts were used to make FRG extracts by the
addition of red yeast rice (Monascus purpureus, CM12002) and
12 h of fermentation at 40C. The FRG was stored at 20C until
use. The FRG contained 4.8 mg Rb1, 3.4 mg Rb2, 0.8 mg Rg1,
2.9 mg Rg2, 4.9 mg Rg3, 1.8 mg Re, and 1.4 mg compound
K per gram. The voucher specimen was deposited in the Veteri-
nary Toxicology Laboratory of Kyungpook National University
(Daegu, Korea).2.2. Animals
Twenty-four-wk-old, female, leptin-deﬁcient (B6.V-Lepob, ‘ob/
ob’) mice were obtained from the Korean Research Institute of
Bioscience and Biotechnology (Daejeon, Korea). The animals were
housed in an environmentally controlled room with a 12-h light/
dark cycle at 22C and relative humidity of 50  5%. The mice were
fed a sterilized (2M rad radiation) pellet diet (Purina, Seoul, Korea)
and had access to sterilized water ad libitum. All animal experiment
protocols were approved by the Institutional Animal Care and Use
Committee of Kyungpook National University.
2.3. Experimental design
A total of 18 female mice were used. The animals were divided
into three groups (n ¼ 6 mice in each group). Group I animals
received drinking water (ﬁltered tap water) and served as the un-
treated control group. Group II animals received drinking water
containing 0.5% FRG and Group III mice received drinking water
with 1% FRG for 16 wk. The effect of FRG on ob/ob mice was
determined by measuring changes in body weight biweekly. Blood
glucose levels were measured using a glucometer (Super Glucocard
II, ARKRAY INC., Kyoto, Japan) after 3 h of fasting. Serum tri-
glycerides weremeasured using theWako L-Type TGM (Wako Pure
Chemical Industries, Ltd., Osaka, Japan) and serum total cholesterol
levels were measured using the Wako Cholesterol E (Wako Pure
Chemical Industries, Ltd.). Serum free fatty acids levels were
measured by an enzymatic colormetric method using Wako NEFA-
HR2 reagents (Wako Pure Chemical Industries, Ltd.). Finally, the
animals were sacriﬁced, and the liver and skeletal muscle (quad-
riceps) were quickly removed for RNA isolation.
2.4. Determination of insulin receptor, lipoprotein lipase, glucose
transporter 1/4, peroxisome proliferators-activated receptor gamma,
and phosphoenolpyruvate carboxykinase mRNA expression
Total RNA was isolated from fresh liver and skeletal muscle us-
ing Easy-BLUE (iNtRON Biotec, Seongnam, Korea) and stored frozen
at 70C. Aliquots of 0.5w5 mL of total RNA from each sample were
reverse-transcribed to complementary DNA (cDNA) using a ﬁrst-
strand cDNA synthesis kit (Fermentas, Vilnius, Lithuania). Poly-
merase chain reaction (PCR) ampliﬁcation of 1w4 mL of cDNA was
carried out in a ﬁnal volume of 20 mL including primer and distilled
water, and using a AccuPower PCR Premix (Bioneer, Daejeon, Ko-
rea). Sequences of the primers used were as follows: glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH; forward: 5ʹ-
CCATCAACGACCCCTTCATTGACC-3ʹ and reverse: 5ʹ-TGGTTCA-
CACCCATCACAAACATG-3ʹ), insulin receptor (IR; forward: 5ʹ-ATG-
GACATCCGGAACAACCT-3ʹ and reverse: 5ʹ-
TTGATGACAGTGGCAGGACA-3ʹ), lipoprotein lipase (LPL; forward:
5ʹ-ATGGAGAGCAAAGCCCTGC-3ʹ and reverse: 5ʹ-AGTCCTTCTG-
CAATCAC-3ʹ), glucose transporter 1 (GLUT1; forward: 5ʹ-
AGGCTTGCTTGTAGAGTGAC-3ʹ and reverse: 5ʹ-TAAGGATGCCAAC-
GACGATTCC-3ʹ), glucose transporter 4 (GLUT4; forward: 5ʹ-
CAACGTGGCTGGGTAGGCA-3ʹ and reverse: 5ʹ-ACA-
CATCAGCCCAGCCGGT-3ʹ), peroxisome proliferator-activated re-
ceptor gamma (PPAR-g; forward: 5ʹ-GGTGAAACTCTGGGAGATTC-3ʹ
and reverse: 5ʹ-CAACCATTGGGTCAGGCTT-3ʹ), and phosphoenol-
pyruvate carboxykinase (PEPCK; forward: 5ʹ-AGCGGA-
TATGGTGGGAAC-3ʹ and reverse: 5ʹ-GGTCTCCACTCCTTGTTC-3ʹ).
The standard ampliﬁcation program included an initial denaturing
step at 94C for 5 min, 30e40 cycles of denaturing at 94C for 30 s,
annealing at 55w60C for 30 s, and extending at 72C for 45e60 s;
and a ﬁnal extension step at 72C for 5 min. The PCR products were
separated by electrophoresis on a 1e1.5% agarose gel, stained with
Fig. 1. Effect of fermented red ginseng (FRG) treatment on body weight in ob/ob mice
for 16 wk. Values are the mean  standard deviation from six animals in each group.
The animals were divided into three groups: control group, 0.5% FRG group, and 1%
FRG group. * Signiﬁcantly different from control (p < 0.05). ** Signiﬁcantly different
from 0.5% FRG (p < 0.05).
Fig. 2. Effect of fermented red ginseng (FRG) treatment on blood glucose level in ob/ob
mice for 16 wk. Values are the mean  standard deviation from six animals in each
group. The animals were divided into three groups: control group, 0.5% FRG group, and
1% FRG group. Blood glucose levels were measured using a glucometer (Super Glu-
cocard II, ARKRAY INC., Kyoto, Japan) after 3 h of fasting. * Signiﬁcantly different from
control (p < 0.05). ** Signiﬁcantly different from 0.5% FRG (p < 0.05).
J.-M. Cheon et al / Fermented red ginseng improves insulin sensitivity 333ethidium bromide, and viewed under UV light using the gel-doc
system (WiseDoc, Daihan Scientiﬁc Co., Seoul, Korea). The abun-
dance of each type of mRNA was normalization relative to GAPDH
mRNA.
2.5. Histological examination
The liver and pancreas were removed, ﬁxed with 4% para-
formaldehyde, and embedded in parafﬁn. Parafﬁn block samples
were cut into 5-mm sections, and stained with hematoxylin and
eosin (H&E) stain and anti-insulin antibody for histological
observation.
2.6. Statistical analysis
The results are presented as the mean  standard deviation.
Data were analyzed using SAS software (version 9.3; SAS Institute
Inc., Cary, NC, USA). Statistically signiﬁcant differences between the
control and FRG-treated groups were analyzed using the Student t
test and analysis of variance. A p value < 0.05 was considered
statistically signiﬁcant.
3. Results
3.1. Body weight changes
Changes in body weight of the experiment groups during the
16-wk FRG treatment period are shown in Fig.1. The bodyweight of
the 0.5% FRG-treated groups was time-dependently decreased
comparedwith the control group, but no statistical signiﬁcancewas
found. The body weight of animals treated with 1.0% FRG signiﬁ-
cantly decreased compared with the controls after 4 wk of
administration.
3.2. Blood glucose levels
The effects of FRG treatment on blood glucose in the ob/obmice
are presented in Fig. 2. Dose-dependent decreases in blood glucose
levels after 3 h of fasting were observed after 16 wk of FRG treat-
ment. However, the blood glucose level of the control group was
consistently moderate hyperglycemia.3.3. Serum contents of triglycerides, total cholesterol, and free fatty
acids
The effects of FRG treatment on the serum contents of tri-
glycerides, total cholesterol, and free fatty acids in the ob/ob mice
are presented in Fig. 3. FRG markedly lowered the triglycerides,
cholesterol, and free fatty acids in the serum of ob/obmice after the
16-wk treatment. However, ob/ob mice in the control group had
moderate hyperlipidemia.
3.4. IR, LPL, GLUT1, GLUT4, PPAR-g, and PEPCK mRNA expression in
skeletal muscle
Fig. 4 shows the effect of FRG on IR, LPL, GLUT1, GLUT4, PPAR-g,
and PEPCK mRNA expression in skeletal muscle. The mRNA ex-
pressions of IR, LPL, and GLUT1 in muscle increased in a dose-
dependent manner in the FRG-treated groups compared with the
control group. GLUT4 and PPAR-gmRNA expression in muscle was
remarkably increased in the 0.5% FRG-treated group compared
with the control group. In particular, the GLUT4 mRNA expression
level of the control group and 1% FRG-treated group were almost
the same. PEPCK mRNA expression in muscle increased in the 1%
FRG-treated group compared with the control group.
3.5. IR, LPL, GLUT1, GLUT4, PPAR-g, and PEPCK mRNA expression in
the liver
Fig. 5 shows the effect of FRG on IR, LPL, GLUT1, GLUT4, PPAR-g,
and PEPCK mRNA expression in the liver. The IR and LPL mRNA
expressions in the liver were increased in the FRG-treated groups
compared with the control group. However, the levels of mRNA
expression of IR and LPL in the 0.5% FRG-treated group were
increased compared with those of the 1% FRG-treated group. The
hepatic GLUT1, GLUT4, and PEPCK mRNA expressions in the 0.5%
FRG-treated group were only increased compared with the control
group. GLUT1, GLUT4, and PEPCK mRNA expressions in the liver
were not detected in the 1.0% FRG-treated group and the control
group. In addition, the hepatic PPAR-g mRNA expression was not
detected in all experimental groups.
Fig. 3. Effects of fermented red ginseng (FRG) treatment on serum levels of triglycerides, total cholesterol, and free fatty acids in ob/ob mice for 16 wk. Values are the
mean  standard deviation from six animals in each group. The animals were divided into three groups: control group, 0.5% FRG group, and 1% FRG group. * Signiﬁcantly different
from control (p < 0.05). ** Signiﬁcantly different from 0.5% FRG (p < 0.05).
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The H&E stained liver sections in FRG treated ob/ob mice are
shown in Fig. 6. In the control group, the histology showed fatty
changes, swelling, and extensive necrosis of hepatocytes in whole
regions. By contrast, FRG treatment showed less severe lobular
damage of hepatocytes in a dose-dependent manner compared
with the control group.
3.7. Histology and immunohistochemical evaluation of the
pancreas
H&E staining of the pancreas did not show any differences in
pancreatic histology between the FRG-treated groups and control
group (Fig. 7, upper panel). Results of immunohistochemical
staining of the insulin (Fig. 7, lower panel) were not signiﬁcantly
different between the FRG-treated groups and control group. These
ﬁndings indicated that FRG did not directly affect insulin produc-
tion and morphology of b-cells.Fig. 4. Insulin receptor (IR), lipoprotein lipase (LPL), glucose transporter 1 and 4
(GLUT1 and GLUT4), peroxisome proliferators-activated receptor gamma (PPAR-g), and
phosphoenolpyruvate carboxykinase (PEPCK) messenger RNA (mRNA) expression in
skeletal muscle. The mRNA expressions of IR, LPL, and GLUT1 in muscle increased in a
dose-dependent manner in fermented red ginseng (FRG)-treated groups compared
with the control group. GLUT4 and PPAR-g mRNA expressions in muscle were
remarkably increased in the 0.5% FRG-treated group compared with the control group
and the 1% FRG-treated group.4. Discussion
We conducted this study to evaluate the antiobesity and anti-
diabetic effects of FRG in old-aged, ob/ob mice. We conﬁrmed that
treatment with FRG alters body weight, blood glucose levels, mRNA
expression of genetic hallmarks of insulin resistance, and histologic
changes. Along the age, obesity and metabolic diseases including
diabetes mellitus have different pathologic conditions. The risk of
developing diabetes mellitus increases with age, particularly
because in humans older adults (>50 yr old) have a greater ten-
dency to be obese [18]. Obesity is abnormal or excessive fat accu-
mulation and is associated with many metabolic diseases such as
diabetes mellitus, cardiovascular disease, hyperlipidemia, and hy-
pertension. Obesity is frequently accompanied by insulin resistance
which leads to the development of type 2 diabetes mellitus. Insulin
resistance is characterized by impaired glucose uptake. Both
decreasing insulin resistance and increasing insulin sensitivity areFig. 5. Insulin receptor (IR), lipoprotein lipase (LPL), glucose transporter 1 and 4
(GLUT1 and GLUT4), peroxisome proliferators-activated receptor gamma (PPAR-g), and
phosphoenolpyruvate carboxykinase (PEPCK) messenger RNA (mRNA) expression in
the liver. The IR and LPL mRNA expressions in the liver were increased in the fer-
mented red ginseng (FRG)-treated groups compared with the control group. However,
the levels of mRNA expression of IR and LPL in the 0.5% FRG-treated group were
increased compared with those of the 1% FRG-treated group. The hepatic GLUT1,
GLUT4, and PEPCK mRNA expressions in the 0.5% FRG-treated group were only
increased compared with the control group.
Fig. 6. Histology of the liver in ob/ob mice treated with fermented red ginseng (FRG) for 16 wk. Hematoxylin and eosin stain. In the control group, the histology showed fatty
changes and swelling of hepatocytes in whole regions. In contrast, FRG treatment showed less severe lobular damage of hepatocytes in a dose-dependent manner compared with
the control group. Original magniﬁcation, 200. Scale bar, 100 mm.
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available drugs for type 2 diabetes mellitus have a number of lim-
itations such as adverse effects and high rates of secondary failure
[19]. Medicinal herbs are expected to have a similar degree of ef-
ﬁcacy without the side effects associated with conventional drug
treatment such as skin irritation and diarrhea [20]. Clinical studies
have shown that ginseng improves pathologic conditions associ-
ated with diabetes mellitus [12,14]. FRG has been treated with red
yeast rice to enhance the ginseng saponin content [15]. Red yeast
rice is a bright, reddishepurple, fermented rice and acquires its
color by being cultivated with the mold Monascus purpureus. This
type of rice is also used for the production of several Chinese wines,
Japanese sake (akaisake), and Korean rice wine (hongju).
Ob/ob mice are a model of obesity and type 2 diabetes mellitus
[21]. These mice are insulin resistant due to a mutation in the gene
that encodes leptin [19], and obesity in ob/obmice is directly caused
by leptin signaling abnormalities such as uncontrolled appetite,
hyperphagia, and reduced energy expenditure mediated by insulin
resistance hallmarks [22]. The pathophysiological characteristics of
ob/obmice resemble those of humanswith type 2 diabetesmellitus.
Because onset and type of obesity and diabetes differs according to
age, the management and treatment of these disorders should vary
according to the relative age. Most animal studies of obesity andFig. 7. Histology and immunohistochemical staining for insulin of the pancreas in ob/obmice
the pancreas did not show any differences in histological appearance between the FRG-treat
the insulin were not signiﬁcantly different between the FRG-treated groups and control grdiabetes mellitus were carried out using young or young adult (4-
wk-old to 12-wk-old) mice, and to the best of our knowledge, no
ginseng-related research using aged ob/ob mice >13 wk old exists,
therefore, we used 24-wk-old ob/ob mice for the present study.
In this study, signiﬁcant decreases in body weight and blood
glucose levels were observed after the administration of 1.0% FRG in
ob/obmice. Bodyweight loss and the hypoglycemic effects of FRG in
ob/ob mice were dose-dependent. Given these results, we can
conﬁrm that the hypoglycemic effect of FRG was evident rather
than the antiobesity effect in old-aged ob/ob mice.
IR mRNA expression in the FRG-treated groups increased, indi-
cating that FRG improved insulin sensitivity. Mice with hetero-
zygotic deletions of both the IR and insulin receptor substrate 1
(IRS-1) show severely impaired insulin action. Furthermore, prog-
eny that are homozygous for both IR and IRS-1 deletions eventually
develop diabetes mellitus [23]. The results of the present study
showed that FRG may improve insulin sensitivity by increasing IR
expression.
LPL mRNA expression in skeletal muscle and in the liver were
also increased in the FRG-treated groups compared with the con-
trol group. LPL is an enzyme that is synthesized in adipose tissue
and muscle. This factor plays a key role in regulating the entry of
triglycerides intomuscle and adipose tissue [24]. The importance oftreated with fermented red ginseng (FRG) for 16 wk. Hematoxylin and eosin staining of
ed groups and control group (upper panel). Results of immunohistochemical staining of
oup (lower panel). Original magniﬁcation, 400. Scale bar, 100 mm.
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that tissue-speciﬁc perturbations in LPL activity result in dramatic
shifts in body composition as well as lipid and glucose metabolism,
particularly in heart and skeletal muscle [25]. LPL levels in muscle
appear to correlate with insulin resistance [26]. LPL depletion in
skeletal muscle reduces lipid storage and increases insulin
signaling without inducing changes in body composition [27].
Moreover, a lack of LPL expression in skeletal muscle results in
insulin resistance in other key metabolic tissues, and ultimately
leads to obesity and systemic insulin resistance [27]. By contrast,
reduced LPL delivery in skeletal muscle increases insulin sensitivity
in skeletal muscle [28]. In the present study, LPL mRNA expression
levels in the liver showed that FRG-treated mice had increased
insulin sensitivity. However, LPL mRNA levels in muscle were also
increased in the FRG-treated groups. Other studies examining the
role of LPL in the development of insulin resistance have been
performed in vitro, or used different models of diabetes mellitus
other than the ob/ob mouse [27,29]. These differences in experi-
mental methods may have affected LPL mRNA expression in mus-
cle, and should be further evaluated in future studies.
In the present study, FRG treatment increased GLUT1 and GLUT4
mRNA expression in ob/ob mice. One of the most important effects
of insulin is the stimulation of GLUT expression in cells. Studies of
GLUT1e5 have shown that each has a speciﬁc role in the control of
sugar homeostasis due to tissue-speciﬁc expression, kinetic char-
acteristics, substrate speciﬁcity, or mechanisms regulating cell
surface expression [6,30e35]. GLUT1 is a nucleotide binding pro-
tein that, when bound to ATP, has a reduced glucose import ca-
pacity but increased afﬁnity for sugars [34]. Sugar transport in
astrocytes, vascular smoothmuscle cells, basal cardiomyocytes, and
cells of the reticuloendothelial system are mediated by GLUT1 [33].
The very high GLUT1 content of higher primate and odontocete
erythrocytes may contribute to glucose transfer from the blood to
tissue [30]. The role of GLUT4 downregulation in the pathogenesis
of insulin resistance and glucose tolerance has been conﬁrmed in
mice with muscle-speciﬁc ablation of GLUT4 [32]. Conversely,
overexpression of GLUT4 in adipose tissue enhances whole body
insulin sensitivity and glucose tolerance [31]. The ability of insulin
to reduce blood glucose levels results from the suppression of he-
patic glucose production and increased glucose uptake in muscle
and adipose tissue via GLUT4 [6]. The results of the present study
showed that FRG improved insulin sensitivity by increasing the
expression of both GLUT1 and GLUT4.
In skeletal muscle, PPAR-g mRNA expression levels were
increased in the FRG-treated groups. PPAR-g is a member of the
nuclear hormone receptor superfamily of ligand-dependent tran-
scription factors and regulates the expression of genes involved in
insulin signaling and lipid metabolism [36,37]. This subtype is
known to play a pivotal role in lipid and carbohydrate metabolism,
and has been implicated in various metabolic and inﬂammatory
disorders such as dyslipidemia, atherosclerosis, diabetes mellitus,
and obesity [38]. PPAR-g is known to have a speciﬁc role in the
etiology of insulin resistance [36,39]. Muscle-speciﬁc PPAR-g
downregulation in mice causes insulin resistance [40]. Our results
showed that FRG decreased insulin resistance by increasing PPAR-g
expression.
PEPCK mRNA expressions in muscle were increased in mice
treated with water containing 1% FRG. PEPCK mRNA expression
levels in the liver were increased in animals administered with
water containing 0.5% FRG. PEPCK is an enzyme that catalyzes the
conversion of oxaloacetate and ATP into phosphoenolpyruvate,
carbon dioxide, and ADP. This factor has two forms: cytosolic and
mitochondrial. Skeletal muscle has a small but signiﬁcant level of
the cytosolic form of PEPCK (PEPCK-C) activity [41], which plays a
role in glyceroneogenesis in skeletal muscle. This tissue containstriglycerides, and glyceroneogenesis is the main contributor to
triglyceride glycerol formation [42]. It has the effect of hyperactivity
on glucose utilization in skeletal muscle (increased insulin sensi-
tivity), and adipose tissue is reduced (reduced leptin formation) in
the PEPCK-Cmus mice (transgenic mice were generated using
PEPCK-C cDNA which was linked to the a-skeletal actin gene pro-
moter). The increased concentration of triglycerides in the skeletal
muscle of PEPCK-Cmus mice is caused by elevated PEPCK-C activity,
which increases the rate of glyceroneogenesis [43]. Deletion of the
PEPCK-C gene in mouse liver leads to ablated hepatic gluconeo-
genesis [44]. Our results showed that FRG improved glyceroneo-
genesis and increased insulin sensitivity in muscle, improved
gluconeogenesis in the liver.
All of the genetic changes observed in the present study indicate
that FRG treatment decreased insulin resistance and increased
glucose utilization. Some of these changes in gene expression due
to FRG were dose-dependent. Although we suppose that differ-
ences in efﬁcacy of FRG due to differences in FRG intake volume, but
volume of water intake during the experimental period was no
notable difference (data not shown). Additional studies with
various concentrations of FRG need to be conducted to further
elucidate the dose-dependent effects of FRG or its active
compound.
Cha et al. [45] reported that the serum contents of total lipid,
triglyceride, total cholesterol, HDL-cholesterol, and free fatty acids
tended to be lowered in the FRG group compared with high-fat
diet-induced hyperlipidemia in rats [45]. This study showed that
FRG markedly lowered the triglycerides, total cholesterol, and free
fatty acids levels in the serum of ob/obmice. Liver histology showed
that FRG treatment ameliorates hepatic pathological changes such
as fatty changes, swelling, and cytoplasmic vacuolization in ob/ob
mice. Therefore, FRG has an effect on the attenuation of hyperlip-
idemia and appears to exert a hepatic regenerative effect on the
histological appearance of the liver in obese and diabetes mellitus
conditions. Immunohistochemistry of becells staining showed that
FRG did not change the morphology of b-cells in old-aged ob/ob
mice.
Previous studies have found that various types of ginseng
reduce body weight in animals with obesity [12,14,17,46]. In this
study, however, FRG treatment less affected the body weight of old-
aged ob/ob mice. Previous studies mostly used young or young-
adult (6w10-wk-old) animals. However, we used relatively older
(24-wk-old) animals in this study. We assume that the age of ani-
mals and the onset and duration of obesity are important factors in
the antiobesity effect in these studies. Further studies about the
antiobesity effect of FRG in young animals are necessary.
In conclusion, we showed that the administration of FRG
signiﬁcantly reduced blood glucose and increased the expression of
IR, LPL, GLUT1, GLUT4, PPAR-g, and PEPCK mRNA in key metabolic
tissues of old-aged ob/ob mice, indicating that FRG improved in-
sulin sensitivity. Decreased blood glucose levels and reduced in-
sulin resistance are key characteristics of treatments for diabetes
mellitus, hence, FRG could be an effective antidiabetic agent, and
may possibly be used as an alternative to supportive treatment for
type 2 diabetes mellitus in old-aged individuals.Conﬂicts of interest
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